The State of New Jersey
NJ Department of Banking and Insurance
search  

Home > Insurance Division > Managed Care > Hemophilia Home Care > Hemophilia-related Services
Hemophilia-related Services
Designated Hemophilia Home Care Providers
Carriers offering health benefits plans that are managed care plans must contract with designated health care providers for the delivery of services for the home treatment of bleeding episodes associated with hemophilia, including the purchase of blood products and blood infusion equipment. (See section 1 of L. 2001, c. 121, codified at N.J.S.A. 26:2S-10.1, and sections 3 through 10 of L. 2001, c. 121, variously codified throughout Titles 17, 17B and 26 of the New Jersey Statutes.) The Department of Banking and Insurance is authorized to designate the hemophilia home care providers. Companies interested in becoming designated should refer to the rules at N.J.A.C. 11:24C-2 (See Statutes and Regulations) for application standards and procedures. The Department will issue a public notice in the New Jersey Register when changes in designation status occur, and will update the web site periodically to reflect those changes.
Designated Hemophilia Home Care Providers
1.
ADIMA d/b/a BioScrip
Effective as of April 12, 2005
2.
ACCREDO Health Group, Inc.
Effective as of June 13, 2005
3.
Caremark Rx, Inc.
Effective as of June 13, 2005
4.
Pediatric Services of America, Inc.
Effective as of June 13, 2005
5.
Children's Hospital Home Care
Effective as of June 13, 2005, for the following counties: Atlantic, Burlington, Camden, Cape May, Cumberland, Gloucester, Hunterdon, Mercer, Middlesex, Monmouth, Ocean, Salem, Somerset
6.
Coram Alternative Site Services
Effective as of February 27, 2006
7.
Curative Critical Care Systems
Effective as of February 27, 2006
8.
New Life Homecare, Inc.
Effective as of February 27, 2006, for the following counties: Essex, Union, Morris, Passaic, Bergen, Monmouth, Ocean, Hudson and Middlesex
9.
OptionCare Hemophilia Services
Effective January 4, 2007
10.
MedPro Rx, Inc.
Effective January 30, 2008
11.
Walnut Home Therapeutics, Inc.
Effective December 10, 2009, for the following counties: Atlantic, Burlington, Camden, Cape May, Cumberland, Gloucester, Mercer, Ocean and Salem
12.
Bleeding Disorders Resource Network, LLC (BDRN)
Effective April 14, 2010
13.
MediLink Homecare, Inc.
Effective June 5, 2012
14.
BioRx, LLC
Effective March 13, 2012
15.
BioMed Pharmaceuticals
Effective January 28, 2014

State-recognized Outpatient Regional Hemophilia Treatment Centers

Under certain conditions, carriers offering health benefits plans that are managed care plans must provide payment to the clinical laboratory at a hospital with a State-recognized outpatient regional hemophilia treatment center for covered services rendered to a covered person with hemophilia, regardless of whether the hospital's clinical laboratory is a participating provider. (See section 2 of L. 2001, c. 121, codified at N.J.S.A. 26:2S-10.2, and sections 3 through 10 of L. 2001, c. 121, variously codified throughout Titles 17, 17B and 26 of the New Jersey Statutes.) Generally, carriers must comply with this requirement when a covered person's attending physician determines it is medically necessary to do so with respect to treatment of the covered person's hemophilia. Rules addressing this issue are set forth at N.J.A.C. 11:24C-3 (See Statutes and Regulations).

The Department elected to specify the hospitals based upon their current federal designation as regional hemophilia treatment centers.

In the event a discrepancy between the list of regional hemophilia treatment centers set forth here and the list set forth by the federal government at: www.cdc.gov/ncbddd/hbd/htc_list.htm, or other current literature issued by the federal government, the information set forth by the federal government controls.

The following are State-recognized outpatient regional hemophilia treatment centers:
 
State-recognized Outpatient Regional Hemophilia Treatment Centers
Children's Hospital of Philadelphia Specialty Center
New Jersey Section of Hematology/Oncology
1012 Laurel Oak Road, Building 1014
Voorhees, NJ 08043
HTC ID: 152
Region III
Children's Hospital of New Jersey
Newark Beth Israel Medical Center
Valerie Fund Children's Center
201 Lyons Avenue at Osborne Terrace
Newark, NJ 07112
HTC ID: 070
Region II
Newark Beth Israel Medical Center
Adult Hematology Programs
201 Lyons Avenue
Newark, NJ 07112
HTC ID: 070
Region II
St. Michael's Medical Center
Nadeene Brunini Comprehensive Hemophilia Care Center
268 Martin Luther King, Jr. Blvd
Newark, NJ 07102
HTC ID: 055
Region II
UMDNJ - Robert Wood Johnson University Hospital
New Jersey Regional Hemophilia Program
Division of Hematology
One Robert Wood Johnson Place
P.O. Box 2601
New Brunswick, NJ 08903-0019
HTC ID: 054
Region II
NOTE: In the event a discrepancy between the list of regional hemophilia treatment centers set forth here and the list set forth by the federal government at www.cdc.gov/ncbddd/hbd/htc_list.htm, or other current literature issued by the federal government, the information set forth by the federal government controls.
 
OPRA
OPRA is a state law that was enacted to give the public greater access to government records maintained by public agencies in New Jersey.
line
Adobe Acrobat
You will need to download the latest version of Adobe Acrobat Reader in order to correctly view and print PDF (Portable Document Format) files from this web site.
state seal
Copyright © 2011, State of New Jersey
New Jersey Department of Banking and Insurance